1 Market Overview

1.1 Anti Influenza Virus Chinese Medicine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Anti Influenza Virus Chinese Medicine Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Oral Solution

1.2.3 Capsule

1.2.4 Lozenges

1.2.5 Chewable Tablets

1.2.6 Aerosol

1.2.7 Injection

1.2.8 Pills

1.2.9 Particles

1.2.10 Syrup

1.3 Market Analysis by Application

1.3.1 Overview: Global Anti Influenza Virus Chinese Medicine Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Adult

1.3.3 Children

1.4 Global Anti Influenza Virus Chinese Medicine Market Size & Forecast

1.4.1 Global Anti Influenza Virus Chinese Medicine Sales in Value (2016-2026))

1.4.2 Global Anti Influenza Virus Chinese Medicine Sales in Volume (2016-2026)

1.4.3 Global Anti Influenza Virus Chinese Medicine Price by Type (2016-2026) & (US$/Unit)

1.5 Global Anti Influenza Virus Chinese Medicine Production Capacity Analysis

1.5.1 Global Anti Influenza Virus Chinese Medicine Total Production Capacity (2016-2026)

1.5.2 Global Anti Influenza Virus Chinese Medicine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Anti Influenza Virus Chinese Medicine Market Drivers

1.6.2 Anti Influenza Virus Chinese Medicine Market Restraints

1.6.3 Anti Influenza Virus Chinese Medicine Trends Analysis

2 Manufacturers Profiles

2.1 Guangzhou Pharmaceutical

2.1.1 Guangzhou Pharmaceutical Details

2.1.2 Guangzhou Pharmaceutical Major Business

2.1.3 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.1.4 Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 CR SANJIU

2.2.1 CR SANJIU Details

2.2.2 CR SANJIU Major Business

2.2.3 CR SANJIU Anti Influenza Virus Chinese Medicine Product and Services

2.2.4 CR SANJIU Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 TASLY

2.3.1 TASLY Details

2.3.2 TASLY Major Business

2.3.3 TASLY Anti Influenza Virus Chinese Medicine Product and Services

2.3.4 TASLY Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 China TCM

2.4.1 China TCM Details

2.4.2 China TCM Major Business

2.4.3 China TCM Anti Influenza Virus Chinese Medicine Product and Services

2.4.4 China TCM Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Yunnan Baiyao

2.5.1 Yunnan Baiyao Details

2.5.2 Yunnan Baiyao Major Business

2.5.3 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product and Services

2.5.4 Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Tongrentang

2.6.1 Tongrentang Details

2.6.2 Tongrentang Major Business

2.6.3 Tongrentang Anti Influenza Virus Chinese Medicine Product and Services

2.6.4 Tongrentang Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Jumpcan

2.7.1 Jumpcan Details

2.7.2 Jumpcan Major Business

2.7.3 Jumpcan Anti Influenza Virus Chinese Medicine Product and Services

2.7.4 Jumpcan Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Zhejiang Conba Pharmaceutical

2.8.1 Zhejiang Conba Pharmaceutical Details

2.8.2 Zhejiang Conba Pharmaceutical Major Business

2.8.3 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.8.4 Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Green Valley Pharma

2.9.1 Green Valley Pharma Details

2.9.2 Green Valley Pharma Major Business

2.9.3 Green Valley Pharma Anti Influenza Virus Chinese Medicine Product and Services

2.9.4 Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Changbaishan Pharmaceutical

2.10.1 Changbaishan Pharmaceutical Details

2.10.2 Changbaishan Pharmaceutical Major Business

2.10.3 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.10.4 Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Zhejiang Kanglaite Pharmaceutical

2.11.1 Zhejiang Kanglaite Pharmaceutical Details

2.11.2 Zhejiang Kanglaite Pharmaceutical Major Business

2.11.3 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.11.4 Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Qingfeng Pharmaceutical Group

2.12.1 Qingfeng Pharmaceutical Group Details

2.12.2 Qingfeng Pharmaceutical Group Major Business

2.12.3 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

2.12.4 Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Buchang Pharmaceutical

2.13.1 Buchang Pharmaceutical Details

2.13.2 Buchang Pharmaceutical Major Business

2.13.3 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.13.4 Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Livzon

2.14.1 Livzon Details

2.14.2 Livzon Major Business

2.14.3 Livzon Anti Influenza Virus Chinese Medicine Product and Services

2.14.4 Livzon Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 ZBD Pharmaceutical

2.15.1 ZBD Pharmaceutical Details

2.15.2 ZBD Pharmaceutical Major Business

2.15.3 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.15.4 ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Chase Sun Pharmaceutical

2.16.1 Chase Sun Pharmaceutical Details

2.16.2 Chase Sun Pharmaceutical Major Business

2.16.3 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.16.4 Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Wuzhou Pharmaceutical

2.17.1 Wuzhou Pharmaceutical Details

2.17.2 Wuzhou Pharmaceutical Major Business

2.17.3 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.17.4 Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.18 Yusheng Pharmaceutical

2.18.1 Yusheng Pharmaceutical Details

2.18.2 Yusheng Pharmaceutical Major Business

2.18.3 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.18.4 Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.19 Harbin Pharmaceutical Group

2.19.1 Harbin Pharmaceutical Group Details

2.19.2 Harbin Pharmaceutical Group Major Business

2.19.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

2.19.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.20 Fusen Pharmaceutical

2.20.1 Fusen Pharmaceutical Details

2.20.2 Fusen Pharmaceutical Major Business

2.20.3 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.20.4 Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.21 Gerun Pharmaceutical

2.21.1 Gerun Pharmaceutical Details

2.21.2 Gerun Pharmaceutical Major Business

2.21.3 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.21.4 Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.22 Shineway Pharmaceutical

2.22.1 Shineway Pharmaceutical Details

2.22.2 Shineway Pharmaceutical Major Business

2.22.3 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.22.4 Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.23 Yiling Pharmaceutical

2.23.1 Yiling Pharmaceutical Details

2.23.2 Yiling Pharmaceutical Major Business

2.23.3 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

2.23.4 Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.24 Harbin Pharmaceutical Group

2.24.1 Harbin Pharmaceutical Group Details

2.24.2 Harbin Pharmaceutical Group Major Business

2.24.3 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

2.24.4 Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Anti Influenza Virus Chinese Medicine Sales by Manufacturer

3.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Anti Influenza Virus Chinese Medicine

3.4 Market Concentration Rate

3.4.1 Top 3 Anti Influenza Virus Chinese Medicine Manufacturer Market Share

3.4.2 Top 6 Anti Influenza Virus Chinese Medicine Manufacturer Market Share

3.5 Global Anti Influenza Virus Chinese Medicine Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Anti Influenza Virus Chinese Medicine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Anti Influenza Virus Chinese Medicine Market Size by Region

4.1.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2016-2026)

4.1.2 Global Anti Influenza Virus Chinese Medicine Revenue by Region (2016-2026)

4.2 North America Anti Influenza Virus Chinese Medicine Revenue (2016-2026)

4.3 Europe Anti Influenza Virus Chinese Medicine Revenue (2016-2026)

4.4 Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue (2016-2026)

4.5 South America Anti Influenza Virus Chinese Medicine Revenue (2016-2026)

4.6 Middle East and Africa Anti Influenza Virus Chinese Medicine Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Type (2016-2026)

5.2 Global Anti Influenza Virus Chinese Medicine Revenue by Type (2016-2026)

5.3 Global Anti Influenza Virus Chinese Medicine Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Anti Influenza Virus Chinese Medicine Sales in Volume by Application (2016-2026)

6.2 Global Anti Influenza Virus Chinese Medicine Revenue by Application (2016-2026)

6.3 Global Anti Influenza Virus Chinese Medicine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Anti Influenza Virus Chinese Medicine Sales by Type (2016-2026)

7.2 North America Anti Influenza Virus Chinese Medicine Sales by Application (2016-2026)

7.3 North America Anti Influenza Virus Chinese Medicine Market Size by Country

7.3.1 North America Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2016-2026)

7.3.2 North America Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Anti Influenza Virus Chinese Medicine Sales by Type (2016-2026)

8.2 Europe Anti Influenza Virus Chinese Medicine Sales by Application (2016-2026)

8.3 Europe Anti Influenza Virus Chinese Medicine Market Size by Country

8.3.1 Europe Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2016-2026)

8.3.2 Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2016-2026)

9.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2016-2026)

9.3 Asia-Pacific Anti Influenza Virus Chinese Medicine Market Size by Region

9.3.1 Asia-Pacific Anti Influenza Virus Chinese Medicine Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Anti Influenza Virus Chinese Medicine Sales by Type (2016-2026)

10.2 South America Anti Influenza Virus Chinese Medicine Sales by Application (2016-2026)

10.3 South America Anti Influenza Virus Chinese Medicine Market Size by Country

10.3.1 South America Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2016-2026)

10.3.2 South America Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2016-2026)

11.2 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2016-2026)

11.3 Middle East & Africa Anti Influenza Virus Chinese Medicine Market Size by Country

11.3.1 Middle East & Africa Anti Influenza Virus Chinese Medicine Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Anti Influenza Virus Chinese Medicine Typical Distributors

12.3 Anti Influenza Virus Chinese Medicine Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Anti Influenza Virus Chinese Medicine Revenue by Type, (USD Million), 2021-2026

Table 2. Global Anti Influenza Virus Chinese Medicine Revenue by Application, (USD Million), 2021-2026

Table 3. Guangzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 4. Guangzhou Pharmaceutical Major Business

Table 5. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 6. Guangzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. CR SANJIU Basic Information, Manufacturing Base and Competitors

Table 8. CR SANJIU Major Business

Table 9. CR SANJIU Anti Influenza Virus Chinese Medicine Product and Services

Table 10. CR SANJIU Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. TASLY Basic Information, Manufacturing Base and Competitors

Table 12. TASLY Major Business

Table 13. TASLY Anti Influenza Virus Chinese Medicine Product and Services

Table 14. TASLY Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. China TCM Basic Information, Manufacturing Base and Competitors

Table 16. China TCM Major Business

Table 17. China TCM Anti Influenza Virus Chinese Medicine Product and Services

Table 18. China TCM Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Yunnan Baiyao Basic Information, Manufacturing Base and Competitors

Table 20. Yunnan Baiyao Major Business

Table 21. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Product and Services

Table 22. Yunnan Baiyao Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Tongrentang Basic Information, Manufacturing Base and Competitors

Table 24. Tongrentang Major Business

Table 25. Tongrentang Anti Influenza Virus Chinese Medicine Product and Services

Table 26. Tongrentang Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Jumpcan Basic Information, Manufacturing Base and Competitors

Table 28. Jumpcan Major Business

Table 29. Jumpcan Anti Influenza Virus Chinese Medicine Product and Services

Table 30. Jumpcan Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Zhejiang Conba Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 32. Zhejiang Conba Pharmaceutical Major Business

Table 33. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 34. Zhejiang Conba Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Green Valley Pharma Basic Information, Manufacturing Base and Competitors

Table 36. Green Valley Pharma Major Business

Table 37. Green Valley Pharma Anti Influenza Virus Chinese Medicine Product and Services

Table 38. Green Valley Pharma Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Changbaishan Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 40. Changbaishan Pharmaceutical Major Business

Table 41. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 42. Changbaishan Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Zhejiang Kanglaite Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 44. Zhejiang Kanglaite Pharmaceutical Major Business

Table 45. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 46. Zhejiang Kanglaite Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Qingfeng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table 48. Qingfeng Pharmaceutical Group Major Business

Table 49. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

Table 50. Qingfeng Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 52. Buchang Pharmaceutical Major Business

Table 53. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 54. Buchang Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Livzon Basic Information, Manufacturing Base and Competitors

Table 56. Livzon Major Business

Table 57. Livzon Anti Influenza Virus Chinese Medicine Product and Services

Table 58. Livzon Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. ZBD Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 60. ZBD Pharmaceutical Major Business

Table 61. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 62. ZBD Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Chase Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 64. Chase Sun Pharmaceutical Major Business

Table 65. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 66. Chase Sun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Wuzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 68. Wuzhou Pharmaceutical Major Business

Table 69. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 70. Wuzhou Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. Yusheng Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 72. Yusheng Pharmaceutical Major Business

Table 73. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 74. Yusheng Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 75. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table 76. Harbin Pharmaceutical Group Major Business

Table 77. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

Table 78. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 79. Fusen Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 80. Fusen Pharmaceutical Major Business

Table 81. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 82. Fusen Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 83. Gerun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 84. Gerun Pharmaceutical Major Business

Table 85. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 86. Gerun Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 87. Shineway Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 88. Shineway Pharmaceutical Major Business

Table 89. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 90. Shineway Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 91. Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 92. Yiling Pharmaceutical Major Business

Table 93. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Product and Services

Table 94. Yiling Pharmaceutical Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 95. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table 96. Harbin Pharmaceutical Group Major Business

Table 97. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Product and Services

Table 98. Harbin Pharmaceutical Group Anti Influenza Virus Chinese Medicine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 99. Global Anti Influenza Virus Chinese Medicine Sales by Manufacturer (2019-2021e) & (K Units)

Table 100. Global Anti Influenza Virus Chinese Medicine Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 101. Market Position of Manufacturers in Anti Influenza Virus Chinese Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 102. Global Anti Influenza Virus Chinese Medicine Production Capacity by Company, (K Units): 2020 VS 2021

Table 103. Head Office and Anti Influenza Virus Chinese Medicine Production Site of Key Manufacturer

Table 104. Anti Influenza Virus Chinese Medicine New Entrant and Capacity Expansion Plans

Table 105. Anti Influenza Virus Chinese Medicine Mergers & Acquisitions in the Past Five Years

Table 106. Global Anti Influenza Virus Chinese Medicine Sales by Region (2016-2021e) & (K Units)

Table 107. Global Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (K Units)

Table 108. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2016-2021e) & (USD Million)

Table 109. Global Anti Influenza Virus Chinese Medicine Revenue by Region (2021-2026) & (USD Million)

Table 110. Global Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 111. Global Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 112. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2016-2021e) & (USD Million)

Table 113. Global Anti Influenza Virus Chinese Medicine Revenue by Type (2021-2026) & (USD Million)

Table 114. Global Anti Influenza Virus Chinese Medicine Price by Type (2016-2021e) & (US$/Unit)

Table 115. Global Anti Influenza Virus Chinese Medicine Price by Type (2021-2026) & (US$/Unit)

Table 116. Global Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 117. Global Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 118. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2016-2021e) & (USD Million)

Table 119. Global Anti Influenza Virus Chinese Medicine Revenue by Application (2021-2026) & (USD Million)

Table 120. Global Anti Influenza Virus Chinese Medicine Price by Application (2016-2021e) & (US$/Unit)

Table 121. Global Anti Influenza Virus Chinese Medicine Price by Application (2021-2026) & (US$/Unit)

Table 122. North America Anti Influenza Virus Chinese Medicine Sales by Country (2016-2021e) & (K Units)

Table 123. North America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Units)

Table 124. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2021e) & (USD Million)

Table 125. North America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (USD Million)

Table 126. North America Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 127. North America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 128. North America Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 129. North America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 130. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2016-2021e) & (K Units)

Table 131. Europe Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Units)

Table 132. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2021e) & (USD Million)

Table 133. Europe Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (USD Million)

Table 134. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 135. Europe Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 136. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 137. Europe Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 138. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2016-2021e) & (K Units)

Table 139. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Region (2021-2026) & (K Units)

Table 140. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2016-2021e) & (USD Million)

Table 141. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue by Region (2021-2026) & (USD Million)

Table 142. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 143. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 144. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 145. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 146. South America Anti Influenza Virus Chinese Medicine Sales by Country (2016-2021e) & (K Units)

Table 147. South America Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Units)

Table 148. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2021e) & (USD Million)

Table 149. South America Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (USD Million)

Table 150. South America Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 151. South America Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 152. South America Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 153. South America Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 154. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Country (2016-2021e) & (K Units)

Table 155. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Country (2021-2026) & (K Units)

Table 156. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2016-2021e) & (USD Million)

Table 157. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue by Country (2021-2026) & (USD Million)

Table 158. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2016-2021e) & (K Units)

Table 159. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Type (2021-2026) & (K Units)

Table 160. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2016-2021e) & (K Units)

Table 161. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales by Application (2021-2026) & (K Units)

Table 162. Direct Channel Pros & Cons

Table 163. Indirect Channel Pros & Cons

Table 164. Anti Influenza Virus Chinese Medicine Typical Distributors

Table 165. Anti Influenza Virus Chinese Medicine Typical Customers

List of Figures

Figure 1. Anti Influenza Virus Chinese Medicine Picture

Figure 2. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type in 2020

Figure 3. Oral Solution

Figure 4. Capsule

Figure 5. Lozenges

Figure 6. Chewable Tablets

Figure 7. Aerosol

Figure 8. Injection

Figure 9. Pills

Figure 10. Particles

Figure 11. Syrup

Figure 12. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application in 2020

Figure 13. Adult

Figure 14. Children

Figure 15. Global Anti Influenza Virus Chinese Medicine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 16. Global Anti Influenza Virus Chinese Medicine Market Size and Forecast (2016-2026) & (USD Million)

Figure 17. Global Anti Influenza Virus Chinese Medicine Sales (2016-2026) & (K Units)

Figure 18. Global Anti Influenza Virus Chinese Medicine Price by Type (2016-2026) & (US$/Unit)

Figure 19. Global Anti Influenza Virus Chinese Medicine Production Capacity (2016-2026) & (K Units)

Figure 20. Global Anti Influenza Virus Chinese Medicine Production Capacity by Geographic Region: 2020 VS 2021

Figure 21. Anti Influenza Virus Chinese Medicine Market Drivers

Figure 22. Anti Influenza Virus Chinese Medicine Market Restraints

Figure 23. Anti Influenza Virus Chinese Medicine Market Trends

Figure 24. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Manufacturer in 2020

Figure 25. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Manufacturer in 2020

Figure 26. Anti Influenza Virus Chinese Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. Top 3 Anti Influenza Virus Chinese Medicine Manufacturer (Revenue) Market Share in 2020

Figure 28. Top 6 Anti Influenza Virus Chinese Medicine Manufacturer (Revenue) Market Share in 2020

Figure 29. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2016-2026)

Figure 30. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2016-2026)

Figure 31. North America Anti Influenza Virus Chinese Medicine Revenue (2016-2026) & (USD Million)

Figure 32. Europe Anti Influenza Virus Chinese Medicine Revenue (2016-2026) & (USD Million)

Figure 33. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue (2016-2026) & (USD Million)

Figure 34. South America Anti Influenza Virus Chinese Medicine Revenue (2016-2026) & (USD Million)

Figure 35. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue (2016-2026) & (USD Million)

Figure 36. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2016-2026)

Figure 37. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Type (2016-2026)

Figure 38. Global Anti Influenza Virus Chinese Medicine Price by Type (2016-2026) & (US$/Unit)

Figure 39. Global Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 40. Global Anti Influenza Virus Chinese Medicine Revenue Market Share by Application (2016-2026)

Figure 41. Global Anti Influenza Virus Chinese Medicine Price by Application (2016-2026) & (US$/Unit)

Figure 42. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2016-2026)

Figure 43. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 44. North America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2016-2026)

Figure 45. North America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2016-2026)

Figure 46. United States Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2016-2026)

Figure 50. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 51. Europe Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2016-2026)

Figure 52. Europe Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2016-2026)

Figure 53. Germany Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2016-2026)

Figure 59. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Anti Influenza Virus Chinese Medicine Sales Market Share by Region (2016-2026)

Figure 61. Asia-Pacific Anti Influenza Virus Chinese Medicine Revenue Market Share by Region (2016-2026)

Figure 62. China Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Korea Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2016-2026)

Figure 69. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 70. South America Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2016-2026)

Figure 71. South America Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Type (2016-2026)

Figure 75. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Application (2016-2026)

Figure 76. Middle East & Africa Anti Influenza Virus Chinese Medicine Sales Market Share by Country (2016-2026)

Figure 77. Middle East & Africa Anti Influenza Virus Chinese Medicine Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Egypt Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. South Africa Anti Influenza Virus Chinese Medicine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Sales Channel: Direct Channel vs Indirect Channel

Figure 83. Methodology

Figure 84. Research Process and Data Source